India AI Summit 2026: Experts discuss what artificial intelligence readiness means for primary healthcare and how frontline workers can adopt it safely and effectively
A good death, according to doctors, is not about stopping treatment but about shifting focus to comfort, dignity and patient wishes before crisis forces rushed decisions
At Bharat Mandapam, the India AI Impact Summit 2026 spotlights how AI is reshaping healthcare delivery, from digital records and teleconsultations to ethical, population-scale deployment
The new ICMR directive pushes for Indian-centric medical research, recognising genetic, dietary and environmental differences in disease patterns
Report points to a structural shift in India's $54 billion healthcare market as focused, asset-light providers scale alongside large hospitals
Budget 2026 puts mental health, biopharma manufacturing and medical skilling at the centre, with Nimhans 2.0 and drug affordability shaping a broader healthcare realignment
Union Budget 2026 proposes measures across biopharma manufacturing, medical education, research, affordable drugs, AYUSH and medical tourism, signalling a deeper healthcare strategy
Finance Minister Nirmala Sitharaman announced measures in the Union Budget 2026-27 to boost medical tourism, including support for five regional hubs in partnership with states and the private sector
A study found that nearly half of the underweight and obese individuals among the 1,000 young adults surveyed for body weight issues experienced moderate to severe concerns, including feeling self-consciousness and lacking confidence. Over a third of the participants (37.5 per cent) felt judged by others, while around a fourth (24.5 per cent) often experienced anxiety related to their weight, researchers from the All India Institute of Medical Sciences (AIIMS), New Delhi, said. The findings published in the Journal of Education and Health Promotion also indicated that feeling self-conscious was significantly associated with obesity, while lack of confidence was most severe among the underweight participants. "Nearly half of the underweight (47.1 per cent) and obese (49.6 per cent) young adults experienced moderate to severe body image concerns, compared to their normal weight (35.8 per cent) and overweight (35.5 per cent) counterparts, who predominantly reported mild levels of ...
Aurobindo Pharma on Thursday said the US health regulator has issued a Form 483 with five observations after inspecting Andhra Pradesh-based Unit-IV of its subsidiary APL Healthcare. The US Food and Drug Administration (USFDA) inspected the unit from December 8 to December 17, 2025, the Hyderabad-based drug firm said in a regulatory filing. "At the end of the inspection, a 'Form 483' was issued with 5 observations which are procedural in nature, and we will respond to the US FDA within the stipulated timelines," it added. The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe, the drug firm said. As per the US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts. Shares of Aurobindo Pharma were trading 0.83 per ..
Earlier on Wednesday, the Lok Sabha passed a Bill aimed at increasing excise duty on tobacco products and their manufacturing after a discussion
Officials say upcoming predictive model will integrate AI surveillance, climatic and population movement patterns to anticipate outbreak trajectories
The AI-powered platform aims to help working professionals manage cardiometabolic risks through heart-age tracking, personalised nutrition, and guided exercise
A team at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, has reported a significant rise in infections caused by a lesser-known bacterium that mimics whooping cough in north India, officials said on Thursday. Pertussis, commonly known as whooping cough, is a highly contagious respiratory illness that has historically been a major cause of childhood mortality, with fatality rates reaching 10 per cent in the early 20th century, a PGIMER statement noted. The study, titled 'Emergence of Bordetella holmesiiAssociated Pertussis-Like Illness, Northern India, 20192023', was published in the Emerging Infectious Diseases journal (of the Centers for Disease Control and Prevention, USA) and analysed 935 suspected pertussis cases. Researchers discovered that nearly 37 per cent of infections were caused by Bordetella holmesii (bacterium), surpassing the number of infections from Bordetella pertussis, which used to be relatively more common. The most significan
The Jharkhand government has received the Centre's nod to a proposal for setting up four medical colleges under the public-private partnership (PPP) in the state, according to an official statement. The new medical colleges will come up in Khunti with a capacity of 50 MBBS seats, Jamtara, Dhanbad and Giridih, with 100 seats each, it said. The approval has been granted under the Centre's 'Scheme for Establishment of Medical Colleges in PPP Mode', which aims to expand medical education across the country and strengthen healthcare services. During a meeting with officials of the Department of Economic Affairs (DEA) in New Delhi on Tuesday, Jharkhand's Health and Medical Education Department Additional Chief Secretary Ajoy Kumar Singh made a presentation, the release said. "After the presentation, the Centre gave its nod to the state's proposal," it added. Singh said, "The opening of medical colleges under the PPP mode will improve medical education and healthcare services in the stat
Indian pharmaceutical and healthcare sector recorded a total of 72 transactions valued at USD 3.5 billion in the third quarter ended September this year, according to Grant Thornton Bharat's dealtracker. This included three IPOs worth USD 428 million and one QIP worth USD 88 million, Grant Thornton Bharat said in a statement. Excluding public market activity, private deals accounted for USD 3 billion across 68 transactions, marking a sharp rebound in investor appetite, it added. The surge was driven by seven high value deals worth USD 2.6 billion, reflecting renewed investor confidence in scale and consolidation plays across pharma, biotech, and hospital segments, and mirroring the sector's strong fundamentals and growth potential. The standout transaction of the quarter was Torrent Pharma's USD 1.4 billion acquisition of a 46 per cent stake in JB Chemicals & Pharmaceuticals, strengthening its position in high-growth therapeutic segments and chronic care markets, it added. "Q3 ...
The World Bank on Friday said it has approved a USD 280 million loan for a health system programme in Kerala to improve the life expectancy and quality of life for 11 million elderly and vulnerable people. The programme aims to treat and support over 90 per cent of patients registered for hypertension and diabetes in the state through individual electronic tracking mechanisms. It will also establish a home-based care model for bedbound, homebound, and vulnerable elderly to provide comprehensive health services. "The World Bank's Board of Executive Directors have approved a new programme to improve the life expectancy and quality of life for 11 million elderly and vulnerable people in the state of Kerala through wider access to health coverage and resilient health systems," the World Bank said in a statement. The USD 280 million Kerala Health System Improvement Programme will build a more comprehensive health system resistant to climate shocks. It will also strengthen Kerala's digita
Amid growing demand for stricter compliance with safety and quality control norms for medical products, the Centre is framing a law to strengthen the legal framework for drug quality testing and market surveillance, along with regulation of medical devices and cosmetics. One of the major reasons behind the drafting of the law is the repeated complaints and concerns flagged by health regulators across the globe, including the WHO, over serious quality lapses by Indian drug manufacturers. The draft of the 'Drugs, Medical Devices and Cosmetics Act 2025', which the government aims to introduce in the upcoming Winter session of Parliament, was presented by Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi at a high-level meeting of the Union health ministry held on Tuesday, the sources said. The meeting was chaired by Union Health Minister J P Nadda. During the meeting, senior officials from the Drugs Controller General of India (DCGI) and the Central Drugs Standard Control
Minister expressed happiness and stated that the Ayushman Bharat scheme had become the world's largest health coverage programme
A global study says basic eye care like screenings and glasses can yield ₹16 for every ₹1 spent, boosting India's productivity and education outcomes